Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Aug 26, 2026, 4:00 PM EDT
1.200
0.00 (0.00%)
After-hours: Aug 26, 2026, 5:36 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $13.94 million as of August 26, 2026. Its market cap has increased by 22.33% in one year.
Market Cap
13.94M
Enterprise Value
944.70K
1-Year Change
22.33%
Ranking
Category
Stock Price
$1.20
ChartMarket Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $13.94M, a decrease of -14.06%. That is a compound annual growth rate of -1.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 13.94M | 23.34% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.65M |
| Passage Bio | 15.54M |
| Akari Therapeutics, | 15.32M |
| Adial Pharmaceuticals | 15.28M |
| Moolec Science | 14.94M |
| NeuroSense Therapeutics | 14.13M |
| SeaStar Medical Holding | 14.01M |
| GT Biopharma | 13.52M |